Mulherkar R - Search Results

1

MEF-2 isoforms' (A-D) roles in development and tumorigenesis.

Madugula K, Mulherkar R, Khan ZK, Chigbu DI, Patel D, Harhaj EW, Jain P. Madugula K, et al. Among authors: mulherkar r. Oncotarget. 2019 Apr 12;10(28):2755-2787. doi: 10.18632/oncotarget.26763. eCollection 2019 Apr 12. Oncotarget. 2019. PMID: 31105874 Free PMC article. Review.

2

In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.

Mulherkar R, Karabudak A, Ginwala R, Huang X, Rowan A, Philip R, Murphy EL, Clements D, Ndhlovu LC, Khan ZK, Jain P. Mulherkar R, et al. Vaccine. 2018 Aug 9;36(33):5046-5057. doi: 10.1016/j.vaccine.2018.07.002. Epub 2018 Jul 10. Vaccine. 2018. PMID: 30005946 Free PMC article.

3

Side Effects.

Mulherkar R, Mulherkar T. Mulherkar R, et al. Pract Radiat Oncol. 2023 Sep-Oct;13(5):390-392. doi: 10.1016/j.prro.2023.05.006. Epub 2023 Jun 7. Pract Radiat Oncol. 2023. PMID: 37290671 No abstract available.

4

National patterns of care for early-stage penile cancers in the United States: How is radiation and brachytherapy utilized?

Mulherkar R, Hasan S, Wegner RE, Verma V, Glaser SM, Kalash R, Beriwal S, Horne ZD. Mulherkar R, et al. Brachytherapy. 2019 Jul-Aug;18(4):503-509. doi: 10.1016/j.brachy.2019.04.007. Epub 2019 May 22. Brachytherapy. 2019. PMID: 31126857

5

Emerging role of immunotherapy in locally advanced non-small cell lung cancer.

Mulherkar R, Grewal AS, Berman AT. Mulherkar R, et al. Clin Adv Hematol Oncol. 2020 Apr;18(4):212-217. Clin Adv Hematol Oncol. 2020. PMID: 32628649 Review.

6

A primer on time-driven activity-based costing in brachytherapy.

Mulherkar R, Keller A, Showalter TN, Thaker N, Beriwal S. Mulherkar R, et al. Brachytherapy. 2022 Jan-Feb;21(1):43-48. doi: 10.1016/j.brachy.2021.05.008. Epub 2021 Aug 8. Brachytherapy. 2022. PMID: 34376368 Review.

7

Effect of short-term corticosteroid usage on acute urinary toxicity following Cs-131 prostate brachytherapy.

Keller A, Abdelhakiem M, Mulherkar R, Ghanta S, Benoit R, Smith RP, Beriwal S. Keller A, et al. Among authors: mulherkar r. Brachytherapy. 2022 Jul-Aug;21(4):468-474. doi: 10.1016/j.brachy.2022.03.006. Epub 2022 May 2. Brachytherapy. 2022. PMID: 35514004

8

Outcomes of 3D MRI based HDR brachytherapy with hybrid multichannel vaginal cylinder applicator and freehand needles for treatment of vaginal disease.

Mulherkar R, Keller A, Houser CJ, Kim H, Doraisamy E, Baig T, Barry P, Vargo JA, Beriwal S. Mulherkar R, et al. Brachytherapy. 2023 Jan-Feb;22(1):66-71. doi: 10.1016/j.brachy.2022.09.002. Epub 2022 Oct 17. Brachytherapy. 2023. PMID: 36266203

9

Role of simulation-based training and assessment to improve brachytherapy competency among radiation oncology residents.

Mulherkar R, Shah C, Bulat M, Thaker NG, Kamrava M, Beriwal S. Mulherkar R, et al. Brachytherapy. 2024 Apr 19:S1538-4721(24)00042-4. doi: 10.1016/j.brachy.2024.02.010. Online ahead of print. Brachytherapy. 2024. PMID: 38643045 Review.

10

Quality of Radiotherapy Workforce Training within the USA.

Mulherkar R, Ling DC, Tendulkar R, Kamrava MR, Beriwal S. Mulherkar R, et al. Clin Oncol (R Coll Radiol). 2024 Feb 2:S0936-6555(24)00048-7. doi: 10.1016/j.clon.2024.01.019. Online ahead of print. Clin Oncol (R Coll Radiol). 2024. PMID: 38331669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page